【结 构 式】 |
【药物名称】 【化学名称】2-(Cyclohexyloxy)-6-(3,5-dimethylbenzyl)-5-methylpyrimidin-4(3H)-one 【CA登记号】 【 分 子 式 】C20H26N2O2 【 分 子 量 】326.44242 |
【开发单位】 【药理作用】 |
合成路线1
Condensation of 2-methyl-4-(3,5-dimethylphenyl)-3-oxobutanoic acid methyl ester (I) with O-methyl isourea (II) led to the formation of 5-methyl-6-(3,5-dimethylbenzyl)-3,4-dihydro-2-methoxy-4-oxopyrimidine (III). Subsequent displacement of the methoxy group linked at C-2 of the pyrimidine ring by treatment with cyclohexoxy potassium salt furnished 2-cyclohexoxy-5-methyl-6-(3,5-dimethylphenyl)-3,4-dihydro-4-oxopyrimidine
【1】 Artico, M.; Selected non-nucleoside reverse transcriptase inhibitors (NNRTIs): the DABOs family. Drugs Fut 2002, 27, 2, 159. |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 51781 | methyl (Z)-4-(3,5-dimethylphenyl)-3-hydroxy-2-methyl-2-butenoate | C14H18O3 | 详情 | 详情 | |
(II) | 26657 | O-methyl isourea; [Amino(imino)methoxy]methane | 52328-05-9 | C2H6N2O | 详情 | 详情 |
(III) | 51782 | 6-(3,5-dimethylbenzyl)-2-methoxy-5-methyl-4(3H)-pyrimidinone | C15H18N2O2 | 详情 | 详情 | |
(IV) | 51780 | sodium cyclohexanolate | C6H11NaO | 详情 | 详情 |
Extended Information